Inclusion/Exclusion Criteria
Inclusion:
To be eligible to enter the trial participants must fulfil all of the following:
- Diagnosis of LFS from confirmed pathogenic TP53 variant (class IV or V by CanVIG-UK criteria (see appendix 2)
- Aged ≥16 years
- Capable of understanding the consent process and participating in the trial and according to the investigators’ discretion.
Exclusion:
- Currently taking metformin
- Metformin intake for more than 3 months in total, within the 2 years antecedent to the date of trial enrolment
- Completion of cancer systemic therapy within the 6 months antecedent to the date of trial enrolment
- Current type 1 or 2 diabetes mellitus
- Presence of active ongoing cancer /or currently receiving cancer treatment (excluding maintenance treatments e.g., hormones)
- Current pregnancy or lactation
- Gastro-intestinal condition (such as short-bowel syndrome) that would affect absorption of metformin
- Concurrent medical condition (other than LFS) that could result in life expectancy of <5 years
- History of the following cardiac conditions:
- Congestive cardiac failure of > Grade II severity according to the New York Heart Association Functional Classification (defined as symptomatic at less than ordinary levels of activity).
- Ischaemic cardiac event including myocardial infarction within 3 months prior to date of enrolment.
- Uncontrolled cardiac disease, including unstable angina pectoris, uncontrolled hypertension (i.e., sustained systolic BP > 160 mmHg or diastolic BP > 90 mm Hg)
- Evidence of significant renal impairment eGFR < 50ml/minute/1.73m2
- Liver cirrhosis and/or alkaline phosphatase, aspartate transaminase or alanine transaminase >2.5 x upper limit of normal (ULN)
- Elevated risk of lactic acidosis such as current chronic alcoholism, congenital lactic acidosis, concurrent intake of carbonic anhydrase inhibitor (e.g. acetazolamide)
- Known allergy to metformin
- Does not fulfil MRI Safety Screening criteria (e.g. implanted cardiac pacemaker, post-surgical metal hardware – plates etc) and/or unable to undergo baseline scan.


